Intranasal vaccination of pups with maternally derived antibodies with a modified live canine parvovirus.
The modified live canine parvovirus (CPV) vaccine was used to vaccinate intranasally twenty-five pups with maternal antibody. The vaccine was able to overcome the interference of maternal immunity in rates of 100%, 72.7% and 17.6% in pups with haemagglutination inhibition antibody titre of 40, 80 and 160 respectively.
Buonavoglia
C
C
Istituto di Malattie Infettive e Parassitarie degli Animali, Facoltà di Medicina Veterinaria, Università Bari, Italia.
Cavalli
A
A
Gravino
E
E
Voigt
V
V
Buonavoglia
D
D
de Caprariis
D
D
D000281:Administration, Intranasal; D000818:Animals; D000914:Antibodies, Viral / Q000097:blood; D004283:Dog Diseases / Q000276:immunology / Q000517:prevention & control*; D004285:Dogs; D007112:Immunity, Maternally-Acquired; D010322:Parvoviridae Infections / Q000276:immunology / Q000517:prevention & control / Q000662:veterinary*; D017993:Parvovirus, Canine / Q000276:immunology*; D014611:Vaccination / Q000662:veterinary; D014765:Viral Vaccines / Q000008:administration & dosage / Q000276:immunology*
D000914:Antibodies, Viral; D014765:Viral Vaccines